Financial Metrics Exploration: Understanding Travere Therapeutics Inc (TVTX) Through Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Travere Therapeutics Inc (NASDAQ: TVTX) was $18.18 for the day, down -0.38% from the previous closing price of $18.25. In other words, the price has decreased by -$0.38 from its previous closing price. On the day, 0.98 million shares were traded. TVTX stock price reached its highest trading level at $18.73 during the session, while it also had its lowest trading level at $18.14.

Ratios:

Our analysis of TVTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.68 and its Current Ratio is at 1.71.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on October 21, 2024, Upgraded its rating to Overweight and sets its target price to $27 from $9 previously.

Guggenheim Upgraded its Neutral to Buy on September 09, 2024, while the target price for the stock was maintained at $25.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’24 when Calvin Sandra sold 12,090 shares for $18.30 per share. The transaction valued at 221,258 led to the insider holds 54,927 shares of the business.

Calvin Sandra bought 12,090 shares of TVTX for $221,258 on Nov 25 ’24. On Oct 04 ’24, another insider, LYONS GARY A, who serves as the Director of the company, sold 40,000 shares for $14.73 each. As a result, the insider received 589,101 and left with 51,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1582283648 and an Enterprise Value of 1549406208. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.77. Its current Enterprise Value per Revenue stands at 7.616 whereas that against EBITDA is -6.49.

Stock Price History:

Over the past 52 weeks, TVTX has reached a high of $20.33, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is 7.89%, while the 200-Day Moving Average is calculated to be 77.22%.

Shares Statistics:

TVTX traded an average of 1.90M shares per day over the past three months and 1215080 shares per day over the past ten days. A total of 87.03M shares are outstanding, with a floating share count of 85.72M. Insiders hold about 1.51% of the company’s shares, while institutions hold 97.29% stake in the company. Shares short for TVTX as of 1730332800 were 7991229 with a Short Ratio of 4.21, compared to 1727654400 on 6962090. Therefore, it implies a Short% of Shares Outstanding of 7991229 and a Short% of Float of 11.49.

Most Popular